Pictet North America Advisors SA and other firms have drastically increased their holdings in the Hess Corporation, while others such as Keybank National Association OH and GF Fund Management CO. LTD have cut their stakes. Piper Sandler and UBS have increased their price targets on Hess, supporting the argument that it's currently an attractive investment. In addition, analysts suggest Hess is poised to beat earnings estimates once again. This positive sentiment is also echoed by high-profile investors such as billionaire stock pickers. Despite these bullish perspectives, Hess was removed from the Russell Midcap Growth Index, and some investors are less positive on the company performing in the same pace as NASDAQ. Hess is also to face arbitration related to their deal with Chevron, further impacting their outlook. Increasingly more views are leaning towards the corporation outperforming the industry or it being the best energy dividend stock. Upcoming earnings results, clinical trial outcomes and merger news regarding Chevron acquiring 5% stock will hugely impact Hess's future.
